Old Web
English
Sign In
Acemap
>
Paper
>
Use of Bortezomib in the Treatment of Antibody Mediated Rejection (AMR) in Pediatric Heart Recipients
Use of Bortezomib in the Treatment of Antibody Mediated Rejection (AMR) in Pediatric Heart Recipients
2019
J. Otero
E. Albers
J.M. Friedland-Little
B. Hong
M. Kemna
I. Gimferrer
Yuk M. Law
Keywords:
Intensive care medicine
Antibody
Oncology
Bortezomib
Medicine
Internal medicine
antibody mediated rejection
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]